CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-02. AI was used for research and drafting; the existence of all 3 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 2008 · Search date 2026-08-02 · Methodology v1.0

Ground pecans about 42.5 g/day,
does it really help with Improved insulin resistance?

30-Second Summary
C
Evidence Grade C · 46 · Safety caution
Insulin-resistance markers improved modestly under isocaloric substitution, without clinical-outcome evidence
Pecans can cause tree-nut allergic reactions. People with nut allergy should avoid them and check cross-contact labeling.
What the
research shows
The grade is C with 46 points. In a four-week crossover feeding trial with 26 completers analyzed, replacing foods in an isocaloric control diet with ground pecans lowered fasting insulin by −2.00±0.83 μIU/mL and HOMA-IR by −0.51±0.23. Approximate 95% CIs are −3.63 to −0.37 and −0.96 to −0.06, respectively, but these are surrogate markers rather than diabetes or complications.
What the
ads claim
Pecans are fat- and energy-dense, but this result concerns a four-week isocaloric substitution and laboratory markers, not adding pecans or preventing diabetes.
*

Useful facts when choosing a product

  • Pecans were ground into prepared meals at about 42.5 g/day for a 2,000 kcal diet.
  • The pecan and control diets were matched for energy, total fat, and fiber, so the comparison replaced other foods with pecans.
  • Pecans are fat- and energy-dense tree nuts. A direct energy assay of the trial product was unconfirmed.
  • Pecans can cause tree-nut allergy.
  • Pecans are native to North America.
ID

Chamgap Semantic Classification Code

Candidate index · review held

F.ground-pecans-incorporated-into-prepared-meals.food.insulin-resistance.improve.UNK

Foods and beverages > Ground pecans incorporated into prepared meals > Food consumption > insulin resistance > Improvement claim > Unknown

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 2008 · C 46
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2018 paper by McKay DL et al. and NCT01950806 were cross-checked. First submission was 2013-09-23 and study start was 2014-01, making registration prospective. Insulin-resistance measures were among several registered primary biomarkers. Support came from a USDA cooperative agreement and the National Pecan Shellers Association, which also supplied pecans.

02

Why this is classified as C (46)

Laboratory markers improved statistically, but the standardized contrast was below a conventional moderate effect. This was one 26-person, four-week, mixed-funded trial with no clinical events, giving C with 46 points.

Counterpoint. Independent long-term trials should measure diabetes incidence and patient-centered outcomes.

Rejudgment record. Cross-check applied — Cross-checked the 2018 paper and NCT01950806 for conflicting enrollment counts, prospective registration, multiple biomarkers, approximate confidence intervals, standardized magnitude, and funding

Stored scoring profile
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE~Statistically positive but below the threshold

Stored derived and displayed grades match; this is not a current recalculation or validity check (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Isocaloric replacement with ground pecans improves insulin-resistance markersCMarkers improved modestly over four weeks, but clinical events were not measured.
Pecans are fat- and energy-dense?This is a composition fact, not a graded clinical outcome.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
McKay DL et al., Nutrients, 2018Randomized crossover feeding trial matched for energy, total fat, and fiberPaper: 30 recruited and 26 completed and analyzed; registry: actual enrollment 28USDA cooperative agreement and National Pecan Shellers AssociationFasting insulin and HOMA-IR−2.00±0.83 μIU/mL, approximate 95% CI −3.63 to −0.37; −0.51±0.23, approximate 95% CI −0.96 to −0.06Positive surrogate markers in a small short multiple-biomarker trial
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-08-02).

McKay DL, et al. A Pecan-Rich Diet Improves Cardiometabolic Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. Nutrients. 2018;10:339. DOI: 10.3390/nu10030339.
checked
ClinicalTrials.gov. NCT01950806, The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes.
checked
US FDA. Food Allergies.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-02 · Corrections: none

Cite this verdict

Ground pecans about 42.5 g/day x insulin resistance Evidence Grade C card
[Chamgap] Ground pecans about 42.5 g/day x insulin resistance — Evidence Grade C·46. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/ground-pecans-insulin-resistance/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.